Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Basal Cell 2Tongue Neoplasms 1Sezary Syndrome 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoid Interstitial Pneumonia 1Keratosis, Actinic 1Basal Cell Nevus Syndrome 1

Interventions

HhAntag691 14sonidegib 4methyl 5-aminolevulinate 3Photochemotherapy 3Aminolevulinic Acid 3tazarotene 2cemiplimab 2IPI-926 2Drug Evaluation 21-phenyl-3,3-dimethyltriazene 2silmitasertib 1remetinostat 1prednylidene 1pembrolizumab 1deltacortene 1Tacrolimus 1Risk Factors 1Prednisone 1Nivolumab 1NVP-BKM120 1Mohs Surgery 1Mindfulness 1Midazolam 1Itraconazole 1Ipilimumab 1IFL protocol 1Folfox protocol 1Fluorouracil 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Carcinoma, Basal Cell × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT00472043 2024-08-06

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

Galderma R&D

Phase 3 Completed
66 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

NCT00985829 2009-12-22

Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma

Shahid Beheshti University of Medical Sciences

Phase 1 Completed
28 enrolled 9 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡